Sermorelin, GHRP-6 (5mg / 5mg) Blend – Product Description
Sermorelin, GHRP-6 (5mg / 5mg) Blend is a dual-peptide material supplied exclusively for controlled
laboratory research, analytical testing, and in vitro experimentation. Each vial contains 5mg of
synthetic Sermorelin and 5mg of synthetic GHRP-6 in lyophilized form.
Sermorelin is a synthetic analog of growth hormone-releasing hormone, commonly abbreviated as GHRH.
GHRP-6 is a synthetic hexapeptide studied in connection with growth hormone secretagogue receptor
pathways. The blend provides a standardized material for peptide characterization, receptor-binding
assays, analytical method development, and controlled GH-axis signaling models.
Sermorelin, GHRP-6 (5mg / 5mg) Blend – Research Specifications:
| Product |
Sermorelin, GHRP-6 Blend |
| Unit Size |
Sermorelin 5mg + GHRP-6 5mg |
| Unit Quantity |
1 vial |
| Format |
Lyophilized peptide blend |
| Components |
Synthetic Sermorelin and synthetic GHRP-6 |
| Appearance |
Lyophilized powder |
| Source |
Chemical peptide synthesis |
| Purity / Identity |
Refer to the batch-specific Certificate of Analysis for reported analytical data |
| Analytical Testing |
Review the applicable COA for reported methods and lot-specific results |
| Storage Conditions |
Store sealed in a cool, dry, dark environment. Follow the batch documentation and laboratory SOPs. |
| Intended Use |
Laboratory research, analytical testing, and in vitro experimentation only |
| Restrictions |
Not for human or animal consumption or for clinical, diagnostic, therapeutic, veterinary, food, cosmetic, or supplement use |
What Is a Sermorelin, GHRP-6 Blend? Research Background
Sermorelin is a synthetic peptide corresponding to the biologically active N-terminal portion of
growth hormone-releasing hormone. Laboratory research involving Sermorelin commonly examines peptide
structure, GHRH receptor recognition, ligand-receptor interactions, and associated signaling pathways.
GHRP-6 is a synthetic hexapeptide examined in laboratory models involving the growth hormone
secretagogue receptor. Research applications may include receptor-binding assays, pathway
characterization, analytical comparison, and peptide stability testing.
A combined Sermorelin and GHRP-6 research material allows both peptide classes to be evaluated within
the same controlled experimental framework. Appropriate controls, reference standards, validated
assays, and predefined analytical endpoints are necessary when examining a multi-component formulation.
Researchers requiring individual materials may also review the product pages for
Sermorelin
and
GHRP-6.
Important Research Notice: Nordsci products include access to lot-specific analytical
documentation. Researchers should consult the applicable Certificate of Analysis when conducting
procurement reviews, identity verification, method qualification, or laboratory recordkeeping.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH USE. NOT FOR HUMAN OR ANIMAL
CONSUMPTION. NOT INTENDED FOR CLINICAL, DIAGNOSTIC, THERAPEUTIC, VETERINARY, FOOD, COSMETIC, OR
SUPPLEMENT USE.
Sermorelin, GHRP-6 Blend – Key Research Applications
1. Growth Hormone Pulse Pattern Research
The blend may be examined in controlled laboratory models designed to characterize variables associated
with GH-axis signaling. Researchers should use predefined sampling intervals, appropriate controls, and
validated analytical methods.
2. Hypothalamic–Pituitary Axis Signaling Studies
Laboratory investigations may use the formulation to examine biochemical pathways associated with GHRH
receptors and growth hormone secretagogue receptors. This research context is limited to controlled
experimental and analytical environments.
3. Endocrine Biomarker Response Experiments
Qualified laboratories may measure selected biomarkers associated with a defined experimental model.
Results depend on assay design, reference materials, environmental controls, sample integrity, and the
analytical methods employed.
4. Comparative Multi-Peptide Research Models
The blend may be compared with individual reference compounds or control samples to characterize
differences between single-component and multi-component experimental conditions. Conclusions should
remain limited to the specific model, methods, and material lot evaluated.
Handling and Research Use Considerations
Handle Sermorelin, GHRP-6 Blend according to established laboratory procedures for synthetic peptide
materials. Personnel should use appropriate contamination controls, calibrated equipment, documented
storage conditions, and validated analytical methods.
Protocol Design Considerations: Laboratory variables such as assay timing, temperature,
material concentration, sample preparation, control selection, and instrument calibration can affect
experimental data. These variables should be predefined and documented within the applicable research
protocol.
This information is provided solely for laboratory research and analytical reference. No dosing,
administration, clinical application, or human-use instructions are provided.
Sermorelin, GHRP-6 Blend – Certificate of Analysis (COA)
Lot-specific Certificates of Analysis provide the analytical results reported for the applicable batch.
Depending on the batch documentation, these records may include identity, purity, and related
quality-control data.
Researchers should review the relevant COA before incorporating the material into an experimental
protocol. Documentation should be retained in accordance with institutional requirements and laboratory
standard operating procedures.
Where to Buy Sermorelin, GHRP-6 Blend for Research
Nordsci Peptides supplies Sermorelin, GHRP-6 Blend as a laboratory research material with access to
lot-specific analytical documentation. Research organizations should evaluate product specifications,
COA data, storage requirements, and institutional procurement policies before purchase.
IMPORTANT: This material is supplied exclusively for laboratory research and analytical
use. It is not for human or animal consumption and is not intended for clinical, diagnostic, therapeutic,
veterinary, food, cosmetic, or supplement applications. Purchasers are responsible for compliance with
applicable laws, regulations, institutional policies, and laboratory safety requirements.
Scientific References
- Research literature concerning growth hormone-releasing hormone peptide structure and receptor-associated signaling.
- Laboratory studies examining growth hormone secretagogue receptor ligands and peptide-receptor interactions.
- Analytical research concerning multi-component peptide characterization and comparative assay design.
- Established laboratory standards for peptide identity testing, purity analysis, documentation, and lot traceability.